Skip to main content
. 2026 Jun 30;52(2):224–233. doi: 10.12865/CHSJ.52.02.08

Table 2.

Distribution of CD8 T lymphocytes according to the analyzed parameters

Parameters/ p value

CD8 IT

(PI/ median)

CD8 PT

(PI/ median)

p value

(Student’s t-test)

Histopathological types

TGAC

32.5±18.9/27.5

42.7±25.1/35

0.119

PC-NOS GAC

113.3±31.4/105

146.6±71.1/140

0.329

PC-SRC GAC

117.5±34.1/100

63.1±35.7/60

0.007

MX-GAC

25±22.7/15

68.8±34.4/50

0.006

MC-GAC

2.7±1.8/2

22.8±14.1/20

0.009

p value (Anova test)

<0.001

<0.001

Tumor grades

Low grade

24.2±10.6/25

36.2±12.5/35

<0.001

High grade

68.7±54.3/75

77.3±57.5/60

0.554

p value (Student's test)

<0.001

0.001

Tumor stages

I

20.8±11.7/25

30±13.6/30

0.288

II

39.6±33.5/30

52.1±31.7/47.5

0.288

III

62.7±54.2/40

72.2±59.7/50

0.542

IV

35.3±42.5/17.5

42.5±20.4/35

0.720

p value (Anova test)

0.147

0.179

Lymphovascular invasion

Present

51.6±45/30

61.2±43.9/50

0.370

Absent

43.9±49.9/25

55±55.7/35

0.523

p value  (Student's test)

0.564

0.650

IT: intratumoral; PT: peritumoral; PI: positivity index; TGAC: tubular gastric adenocarcinoma; PC-NOS GAC: poorly cohesive-no other specifications gastric adenocarcinoma; PC-SRC GAC: poorly cohesive-signet ring cells gastric adenocarcinoma; MX-GAC: mixed gastric adenocarcinoma; MC-GAC: mucinous gastric adenocarcinom